Aitia is a company that uses Causal AI and Digital Twins to discover breakthrough drugs. They create Digital Twins of diseases in oncology, neurodegenerative disorders, and immunology by leveraging multi-omic patient data, high-performance computing, and AI. Their Gemini Digital Twins are being used to discover novel therapies and accelerate R&D in various diseases, and they have partnerships with top pharmaceutical companies, academic research centers, and patient advocacy groups globally.